GlassScriptPhysician profile
Carmen M Selman
NPI 1295938090
$2,657.22
in general payments reported to CMS, 2019-2025
24 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $305 · 2021: $496 · 2022: $424 · 2023: $600 · 2024: $222 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.94 |
| Education | $113.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.60 | 2019-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $315.24 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $299.91 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.51 | 2019-2023 | |
| Hologic Sales and Service, LLC | $164.56 | 2022-2025 | Aptima, Affirm Prone Biopsy System, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $146.43 | 2019-2022 | |
| Organon LLC | $145.55 | 2022-2024 | Nexplanon |
| Astellas Pharma US INC | $110.77 | 2023 | Veozah |
| Aspira Women'S Health INC | $93.16 | 2020 | |
| Therapeuticsmd, INC. | $87.61 | 2019-2021 | |
| Pfizer INC. | $86.47 | 2023-2025 | |
| Shield Therapeutics INC | $82.93 | 2024-2025 | |
| Coopersurgical, INC. | $80.31 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $66.28 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Allergan, INC. | $61.74 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $49.53 | 2021-2022 | |
| Exact Sciences Corporation | $48.12 | 2023-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $42.95 | 2022-2024 | |
| Smith+Nephew, INC. | $32.61 | 2022 | |
| Scynexis, INC. | $27.72 | 2022 | |
| Mission Pharmacal Company | $20.17 | 2023 | Citranatal |
| Lupin INC. | $16.56 | 2019 | |
| Biogen, INC. | $16.27 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Selman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.